The DOI matches its Crossref record.
Interactions with the Absorption of Tetracyclines
Abstract
All tetracycline derivatives are bacteriostatics and their concentration in serum should not fall during the therapy below the generally accepted minimum therapeutic concentration of 0.5 to 1.5 mug/ml. Tetracyclines have a high affinity to form chelates with polyvalent metallic cations such as Fe+++, Fe++, Al+++, Mg++ and Ca++. Many of these tetracycline-metal complexes are either insoluble or otherwise poorly absorbable from the gastro-intestinal tract. Milk and other dairy products, antacids containing polyvalent cations, as well as various iron salts ingested simultaneously with tetracycline derivatives, might interfere with their absorption by 50 to 90% or even more. The severity of interaction depends both on the nature of the tetracycline derivative and of the cation, on the doses used, on pharmaceutical factors, and on time schedules in dosing. An interval of 3 hours between the ingestion of tetracyclines and cations prevents the interaction. The pharmacokinetic interactions in absorption of tetracyclines likely to be clinically significant in cases where the infecting pathogens are moderately resistant to tetracyclines and relatively high serum concentrations are needed for proper bacteriostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many healthcare professionals are familiar with the physical binding of drugs such as tetracyclines to divalent and trivalent cations found in milk or antacid preparations or in many ONS and enteral formulas, which limits absorption from the gastrointestinal tract.
“For example, many healthcare professionals are familiar with the physical binding of drugs such as tetracyclines to the divalent and trivalent cations found in milk or antacid preparations [181] or in many of the ONS and enteral formulas, which limits absorption from the gastrointestinal tract.”
From ESPEN guideline on nutritional support for polymorbid medical inpatients (2023) · cites this paper as [181]
Citations
Cited by
Sorted by citations
ESPEN guidelines on nutritional support for polymorbid internal medicine patients
Gomes, F., Schuetz, P., Bounoure, L., Austin, P., Ballesteros-Pomar, M., Cederholm, T., Fletcher, J., Laviano, A., Norman, K., Poulia, K.-A., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.025 · Cited by 363
ESPEN guideline on nutritional support for polymorbid medical inpatients
Wunderle, C., Gomes, F., Schuetz, P., Stumpf, F., Austin, P., Ballesteros-Pomar, M. D., Cederholm, T., Fletcher, J., Laviano, A., Norman, K., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.023 · Cited by 105
“For example, many healthcare professionals are familiar with the physical binding of drugs such as tetracyclines to the divalent and trivalent cations found in milk or antacid preparations [181] or in many of the ONS and enteral formulas, which limits absorption from the gastrointestinal tract.”
Background
Metadata
- Authors
- Neuvonen, P. J.
- Affiliations
- Helsinki University Hospital (FI)
- Corresponding author
- Neuvonen, P.J.
- ORCID
- Neuvonen, P.J.
- Venue
- Drugs
- Published
- 1976
- Volume
- 11
- Issue
- 1
- Pages
- 45-54
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W1988678216
- Cited by
- 230
- References
- 0
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 5 · 2023: 18 · 2022: 13 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 6 · 2017: 6 · 2016: 6 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- tetracycline, drug absorption, drug interactions, metal cations, iron salts, antacids, dairy products, pharmacokinetics, serum drug concentration, bacteriostatic activity, tetracycline resistance, dosing regimen
- MeSH terms
- Animals, Antacids, Chelating Agents, Drug Interactions, Ferric Compounds, Ferrous Compounds, Humans, Intestinal Absorption, Iron, Milk, Tetracyclines, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review